Interpace Biosciences Inc (PDII) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PDII Annual Balance Sheets →
From Interpace Biosciences Inc through Sep 30 2025, shifts in Sep 30 2026's assets and liabilities provide insight into the company's capital structure and financial stability.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/PDII/balance-sheets
https://api.csimarket.com/api/v1/companies/PDII/fundamentals
https://api.csimarket.com/api/v1/companies/PDII/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent2.93
Cash & Short-term Investments2.00
Accounts receivable7.60
Inventories1.27
Derivatives, Collateral, Regulatory, Deferred0.88
Other Current Assets0.58
Total loans net0.02
Total Current Assets13.29
Equipment/Property/Plant Net1.45
Other Assets, Noncurrent22.73
Operating Lease Right Of Use Asset1.11
Total Assets37.47
Liabilities
Accounts Payable, Current AC1.42
Employee-related Liabilities, Current AC2.39
Notes Payable, Current NO0.00
Other Liabilities, Current1.72
Taxes Payable0.25
Disposal Group, Including Discontinued Operation, Liabilities, Current LI0.66
Total Current Liabilities6.44
Total Long-term Debt0.00
Other liabilities, Noncurrent6.34
Operating Lease Liability Noncurrent0.64
Total Liabilities12.78
Stockholders' Equity
Common Stock Value0.64
Treasury Stock Value-3.01
Additional Paid In Capital Common Stock238.60
Retained Earnings / Accumulated Deficit-211.54
Other Equity0.00
Common Stockholder's Equity24.69
Total Stockholder's Equity24.69
Liabilities & Stockholder's Equity37.47
4 historic quarters locked

Sign in to unlock the full Interpace Biosciences Inc balance sheet history.

About Interpace Biosciences Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260930)
  • Filed with the SEC: November 16, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-052379

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI